NCT03938038

Brief Summary

The purpose of this study is to assess the effectiveness of routine ultrasound assessments of volume status and fluid responsiveness for goal-directed therapy (GDT)-based fluid resuscitation in reducing acute kidney injury (AKI) incidence and duration in trauma patients in a teaching institution.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
415

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 6, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

September 6, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2020

Completed
23 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2020

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

April 26, 2024

Completed
Last Updated

April 26, 2024

Status Verified

March 1, 2024

Enrollment Period

10 months

First QC Date

May 2, 2019

Results QC Date

June 30, 2022

Last Update Submit

March 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of Acute Kidney Injury (AKI)-Free Days

    AKI will be defined by the Kidney Disease Improving Global Outcomes (KDIGO) criteria, and all stages will be considered AKI: Stage 1 - Serum Creatinine 1.5-1.9 times baseline or ≥0.3 mg/dL increase Stage 2 - Serum Creatinine 2-2.9 times baseline Stage 3 - Serum Creatinine 3 times baseline or Increase in serum creatinine to ≥4 mg/dL or Initiation of renal replacement therapy

    within 7 days of injury

  • Number of Participants Who Receive 3 or More Ultrasound Volume Assessments

    within 24 hours of ICU admission

Secondary Outcomes (14)

  • Number of Participants With Acute Kidney Injury (AKI)

    within the first 7 days of ICU admission

  • Stage of Acute Kidney Injury (AKI)

    within the first 7 days of ICU admission

  • Number of Participants With Need for Renal Replacement Therapy

    within the first 30 days of ICU admission

  • Quantity of Fluids Administered

    24 hours

  • Quantity of Fluids Administered

    48 hours

  • +9 more secondary outcomes

Study Arms (2)

Serial ultrasound assessments for GDT, then Usual Care

ACTIVE COMPARATOR
Diagnostic Test: Serial ultrasound assessments for GDTDiagnostic Test: Usual care

Usual care, then Serial ultrasound assessments for GDT

ACTIVE COMPARATOR
Diagnostic Test: Serial ultrasound assessments for GDTDiagnostic Test: Usual care

Interventions

routine ultrasound assessments of volume status and fluid responsiveness for goal-directed therapy (GDT)-based fluid resuscitation

Serial ultrasound assessments for GDT, then Usual CareUsual care, then Serial ultrasound assessments for GDT
Usual careDIAGNOSTIC_TEST

Close hemodynamic cardiac monitoring and volume responsiveness assessment on an unscheduled basis to aid physicians in resuscitation feedback

Serial ultrasound assessments for GDT, then Usual CareUsual care, then Serial ultrasound assessments for GDT

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Injured patients that are admitted to the trauma ICU

You may not qualify if:

  • Incarceration
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Results Point of Contact

Title
Gabrielle Hatton, MD
Organization
The University of Texas Health Science Center at Houston

Study Officials

  • Gabrielle Hatton, MD

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Randomization will not occur at the individual patient level. Instead, assessment techniques (US-guided versus usual care) will be randomly assigned to care team clusters. Because teams change each month, the assignment will be to US-guided care during the first half or the second half of the month.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Fellow

Study Record Dates

First Submitted

May 2, 2019

First Posted

May 6, 2019

Study Start

September 6, 2019

Primary Completion

June 27, 2020

Study Completion

July 20, 2020

Last Updated

April 26, 2024

Results First Posted

April 26, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations